Please familiarise yourself with this page so you understand our process and what investors are looking for. As you can imagine our investors hear a lot of pitches and aren't inclined to assess the same team twice, so let's make your first impression strong.
HOME | STARTUPS | INVESTORS | ABOUT US
What we're looking for...
Angels invest when your business is young, so we put a lot of emphasis on the founding team's expertise and ability to execute. You need to demonstrate that you are strong on your numbers, good at attracting talent and focused on customer growth. If you are not 100% dedicated to your startup, it is hard for an investor to be.
Investors are looking for startups with sales in market, or in the case of med/biotech clear progress through research towards commercialisation. Pre-revenue is OK, as long as you have an established team and a customer growth strategy.
The typical pre-money valuation of the startups we see is $1-6 million. Members often consider valuation to be less important than potential return. So your valuation might be higher, but we would expect your product to be far more mature if that's the case.
You have a well-rehearsed pitch with accompanying slides. You know how you will be spending the money to achieve your goals, and you have already worked with your lawyer on the investment terms and shareholder agreement. This is investment-ready.
Your technology should be developed in response to an identified market need. It is solving a significant problem. As result, you can demonstrate customer demand for your product. Eg, a market sentiment survey is not enough. Investors want to see customers and before investing will often speak to them as part of due diligence.
We invest in companies that offer exceptional opportunities for return on investment. Your company might be great, but to return 10x times invested capital in 5-8 years, it needs to be exceptional. A great company might make you wealthy, but it often isn't enough to make others wealthy too.
We need to understand your competitors and your sustainable competitive advantage. What is your IP protection strategy and economic moat to protect your long-term profits and market share? Investors need to have faith in the potential of the product to scale and beat the competition.
This is not a comprehensive list. Investing in nascent companies is an art, not a science. What is your unfair winning advantage?
Click the arrow for more information